ESSD 2021 Programme

All times are listed in Central European Time (CET).

If you are having any technical difficulties with joining the online conference, please write to Emir Handžo at
itsupportessd.powi@univie.ac.at.

Download: Programme ESSD 2021 Online

Programme ESSD 2021 Online final.pdf

DOWNLOAD

File size: 348 kB

Day 1 - Thursday, 30 September 2021

Day 2 - Friday, 1 October 2021

Day 1 - Thursday, 30 September 2021

10:00 ‑ 10:30 CET	Opening of the conference and general information President ESSD Dirk J. Korf (University of Amsterdam) Conference Organisers ESSD 2021 Alfred Uhl (Sigmund Freud Private University, Austrian Public Health Institute) & Meropi Tzanetakis (University of Vienna, University of Innsbruck)
10:30 ‑ 11:30 CET	Session 1: Dynamic drug markets Chair: Tom Decorte (Ghent University)
	The role of Internet and mobile phone in cannabis and stimulants transactions: A survey among users from seven European countries	Kostas Skliamis (University of Amsterdam, Netherlands)
	A trendspotter study of drug supply and associated violence and exploitation of vulnerable groups in Denmark	Thomas Friis Søgaard (Aarhus University, Denmark), Marie H. Bræmer, Michael M. Pedersen
	‘Cuckooing’ as a variable and evolving form of exploitation in street level drug markets	Leah Moyle (Royal Holloway, University of London, United Kingdom), Jack Spicer, Ross Coomber
11:30 ‑ 12:00 CET	Coffee break
12:00 ‑ 13:00 CET	Session 2: Drug policy impacts Chair: Leah Moyle (Royal Holloway, University of London)
	Building cultures of participation: involving young people in contact with the criminal justice system in the development of drug interventions in the UK, Denmark, Italy, and Poland	Karen Duke (Middlesex University, London, United Kingdom), Helen Gleeson, Katarzyna Dabrowska, Maria Dich Herold, Sara Rolando, Betsy Thom
	Neutralizing health issues: an ethnographic analysis of medical services on a Russian cryptomarket	Anastasia Meylakhs (HSE University, Russia), Saidashev Ramil
	From ‘Down with this sort of thing’ to petrol bombs: How the 2010 head shop moral panic influenced the world’s first blanket ban on new psychoactive substances	James Windle (University College Cork, Ireland), Paul Murphy
13:00 ‑ 14:00 CET	Lunch break
14:00 ‑ 15:20 CET	Session 3: Cognitions about drug users and addicts Chair: Dirk Korf (University of Amsterdam)
	Drug abusing family characteristics in terms of internal and external shame, guilt and stigmatization	Nadja Springer (Verein Dialog, Austria)
	Integrating self-regulation theories with the life-course perspective to study patterns in the use of khat	Amanti Baru Olani (Ghent University, Belgium)
	Challenging the structures of expertise on drugs: The rise of NPS, scientific uncertainty, and the increasing value of user knowledge	Luca Elisa Lindner (University of Vienna, Austria)
	Models of recovery: influence of psychosocial factors on substance use	Antonio Molina Fernández (Universidad Complutense de Madrid, Spain) Jesús Saiz Galdós, María Luisa Cuenca Montesino, Francisco Gil Rodríguez
15:20 ‑ 15:50 CET	Coffee break
15:50 ‑ 16:50 CET	Session 4: Cannabis: Innovative approaches Chair: Bernd Werse (Goethe University Frankfurt)
	Digital prevention in different cultural contexts - the case of DAPY project in Turkey and Poland	Michał Wanke (University of Opole, Poland), Ruken Macit
	A typology of frequent cannabis users in Spain. A latent class analysis	Arturo Alvarez-Roldan, (University of Granada, Granada, Spain), Teresa García-Muñoz, Juan F. Gamella, Iván Parra, Maria J. Duaso
	Country, city and cannabis: Riga resident cannabis use settings in Latvia	Kristiana Diana Bebre (University of Latvia, Latvia)
16:50 CET	End of day

Day 2 - Friday, 1 October 2021

10:00 ‑ 11:00 CET	Session 5: Use of performance enhancing drugs Chair: Meropi Tzanetakis (University of Vienna)
	The politics of imagining and building a world for legal psychedelic drug use in Europe and the United States	Claudia Schwarz-Plaschg (University of Vienna, Austria)
	Identifying best-practice amongst health professionals who work with people using image and performance enhancing drugs (IPEDs) through participatory action research	Martin Chandler (University of Birmingham, United Kingdom), Katinka van de Ven, Ian Boardley
	Chemsex – how far can too far go	Alfred Springer, Medical University of Vienna
11:00 ‑ 11:30 CET	Coffee break
11:30 ‑ 12:30 CET	Session 6: Theoretical approaches to drugs Chair: Karen Duke (Middlesex University)
	The earnings model for illegal drugs and the prescient view of the Hulsman Commission	Peter Cohen (retired from University of Amsterdam, Netherlands)
	Theorizing intersectionally with material gerontology and critical drug studies	Aysel Sultan (Frankfurt University of Applied Sciences & Goethe University Frankfurt, Germany)
	It is logically impossible to count the number of indirect deaths	Alfred Uhl (Austrian Public Health Institute & Sigmund Freud Private University, Austria)
12:30 ‑ 13:30 CET	Lunch break
13:30 ‑ 14:50 CET	Session 7: Challenges for knowledge about drugs Chair: Gary Potter (Lancaster University)
	Youth perceptions on non-medical use of psychoactive medications	Frédérique Bawin (Ghent University, Belgium), Julie Tieberghien, Ellen Vandenbogaerde, Mafalda Pardal, Kevin Emplit, Christine Guillain
	Ethnographic drugs research – Ethical and moral challenges of participatory observational research on security at music festivals	Jessica Williamson (University of Manchester, United Kingdom)
	The prevalence of and associated factors with self-reported naloxone carrying among people who inject drugs (PWID) in England, Wales and Northern Ireland	Christiane Spring (University of Bristol, United Kingdom), Sara Croxford, Zoe Ward, Rachel Ayres, Catherine Lord, Adelina Artenie, Peter Vickerman
	Handling the challenges of not having a real life: Drug using and selling among unaccompanied refugee minors in Malmö, Sweden	Anke Stallwitz (Protestant University of Applied Sciences Freiburg, Germany)
14:50 ‑ 15:20 CET	Coffee break
15:20 ‑ 16:20 CET	Session 8: Drugs and COVID-19 Chair: Anke Stallwitz (Protestant University of Applied Sciences Freiburg)
	The impact of the COVID-19 pandemic on male strength athletes who use non-prescribed anabolic-androgenic steroids	Barnaby N. Zoob Carter (University of Birmingham, United Kingdom), Ian D. Boardley, Katinka van de Ven
	Investigating experiences of COVID-19 for individuals in recovery	Emma Smith (University of Worcester, United Kingdom), Melody Carter, Elaine Walklet, Paul Hazell
	Update: Cannabis use and corona virus – results of a second short online survey during the second/third wave in Germany	Bernd Werse (Goethe University Frankfurt, Germany), Gerrit Kamphausen
16:20 ‑ 16:40 CET	Closing session